Developing Growth Fund
Daily price w/o sales charge as of 03/05/2021
$39.14
$0.09
YTD Returns w/o sales charge as of 03/05/2021
0.44%
Overall Morningstar RatingsSmall Growth
as of 02/28/2021
Morningstar rated the Lord Abbett Developing Growth Fund class I share 5, 5 and 4 stars among 575, 505 and 379 Small Growth Funds for the overall rating and the 3, 5 and 10 year periods ended 2/28/2021, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small U.S. companies.
Fund Basicsas of 01/29/2021
- Total Net Assets
- $4.97 B
- Inception Date
- 12/30/1997
- Dividend Frequency
- Annually
- Fund Expense Ratio
- 0.68%
- Number of Holdings
- 106
- Minimum Initial Investment
- $1,000,000+
Fund Expense Ratio :
0.68%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 12/30/1997 |
---|
w/o sales charge | 8.24% | 90.63% | 35.49% | 31.34% | 17.57% | 11.50% |
Lipper Category Avg. Small-Cap Growth Funds | 7.78% | 59.99% | 21.09% | 22.12% | 13.72% | - |
Russell 2000® Growth Index | 8.28% | 58.88% | 18.95% | 21.15% | 13.80% | 8.29% |
Fund Expense Ratio :
0.68%
Fund Expense Ratio :
0.68%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 12/30/1997 |
---|
w/o sales charge | 72.95% | 72.95% | 34.07% | 25.08% | 17.45% | 11.20% |
Lipper Category Avg. Small-Cap Growth Funds | 38.35% | 38.35% | 18.76% | 17.68% | 13.52% | - |
Russell 2000® Growth Index | 34.63% | 34.63% | 16.20% | 16.36% | 13.48% | 7.98% |
Fund Expense Ratio :
0.68%
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 01/29/2021View Portfolio
Holding | Assets |
---|---|
Inspire Medical Systems Inc | 2.0% |
Axon Enterprise, Inc. | 1.8% |
Natera Inc | 1.7% |
MKS Instruments Inc | 1.5% |
RH | 1.5% |
TG Therapeutics Inc | 1.5% |
Axonics Modulation Technologies Inc | 1.4% |
Cardlytics Inc | 1.4% |
Stitch Fix Inc | 1.4% |
SunPower Corp | 1.4% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 01/29/2021View Portfolio
Sector | Weighting |
---|
Sector | Weighting |
---|---|
Communication Services | |
Real Estate | |
Utilities | |
Consumer Discretionary | |
Consumer Staples | |
Energy | |
Financials | |
Health Care | |
Industrials | |
Information Technology | |
Materials |
INVESTMENT TEAM




Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
0.68%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 12/30/1997 |
---|
w/o sales charge | 8.24% | 90.63% | 35.49% | 31.34% | 17.57% | 11.50% |
Lipper Category Avg. Small-Cap Growth Funds | 7.78% | 59.99% | 21.09% | 22.12% | 13.72% | - |
Russell 2000® Growth Index | 8.28% | 58.88% | 18.95% | 21.15% | 13.80% | 8.29% |
Fund Expense Ratio :
0.68%
Fund Expense Ratio :
0.68%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 12/30/1997 |
---|
w/o sales charge | 72.95% | 72.95% | 34.07% | 25.08% | 17.45% | 11.20% |
Lipper Category Avg. Small-Cap Growth Funds | 38.35% | 38.35% | 18.76% | 17.68% | 13.52% | - |
Russell 2000® Growth Index | 34.63% | 34.63% | 16.20% | 16.36% | 13.48% | 7.98% |
Fund Expense Ratio :
0.68%
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
Year | Fund Returns | Russell 2000® Growth Index |
---|
2020 | 72.95% | 34.63% |
2019 | 32.25% | 28.48% |
2018 | 5.37% | -9.31% |
2017 | 30.27% | 22.17% |
2016 | -2.48% | 11.32% |
2015 | -8.64% | -1.38% |
2014 | 3.56% | 5.60% |
2013 | 57.77% | 43.30% |
2012 | 10.73% | 14.59% |
2011 | -1.30% | -2.91% |
2010 | 37.01% | - |
2009 | 47.54% | - |
2008 | -47.31% | - |
2007 | 36.29% | - |
2006 | 12.86% | - |
2005 | 12.31% | - |
2004 | 6.39% | - |
2003 | 40.51% | - |
2002 | -29.25% | - |
2001 | -6.55% | - |
Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
---|
2021 | - | - | - | - | 0.44% |
2020 | -16.89% | 40.70% | 15.98% | 27.53% | 72.95% |
2019 | 27.04% | 9.18% | -11.29% | 7.48% | 32.25% |
2018 | 7.20% | 15.07% | 12.25% | -23.90% | 5.37% |
2017 | 8.45% | 4.10% | 7.18% | 7.67% | 30.27% |
2016 | -10.24% | 2.28% | 10.94% | -4.25% | -2.48% |
2015 | 7.18% | 2.69% | -15.63% | -1.62% | -8.64% |
2014 | 1.76% | 0.24% | -5.71% | 7.66% | 3.56% |
2013 | 13.60% | 10.13% | 18.88% | 6.09% | 57.77% |
2012 | 12.24% | -2.59% | 5.66% | -4.16% | 10.73% |
2011 | 10.32% | 1.61% | -20.78% | 11.16% | -1.30% |
2010 | 8.25% | -7.85% | 16.61% | 17.79% | 37.01% |
2009 | -2.06% | 24.50% | 14.24% | 5.91% | 47.54% |
2008 | -21.75% | 6.69% | -11.69% | -28.53% | -47.31% |
2007 | 4.75% | 13.67% | 9.96% | 4.10% | 36.29% |
2006 | 16.07% | -6.14% | -6.74% | 11.08% | 12.86% |
2005 | -5.76% | 5.86% | 9.71% | 2.62% | 12.31% |
2004 | 2.15% | 0.26% | -6.94% | 11.64% | 6.39% |
2003 | -3.21% | 21.50% | 9.82% | 8.80% | 40.51% |
2002 | 0.13% | -11.79% | -23.72% | 5.00% | -29.25% |
2001 | -17.33% | 16.13% | -22.60% | 25.77% | -6.55% |
2000 | 3.54% | -13.66% | -0.45% | -7.36% | -17.55% |
1999 | 1.48% | 11.84% | -3.36% | 26.59% | 38.85% |
1998 | 11.63% | -2.88% | -21.97% | 28.41% | 8.63% |
1997 | - | - | - | - | 1.70% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
NAV Historical Prices
Date | Net Asset Value |
---|
Portfolio
Portfolio
Holding | Sector | Assets |
---|
Inspire Medical Systems Inc | Health Care | 2.0% |
Axon Enterprise, Inc. | Industrials | 1.8% |
Natera Inc | Health Care | 1.7% |
MKS Instruments Inc | Information Technology | 1.5% |
RH | Consumer Discretionary | 1.5% |
TG Therapeutics Inc | Health Care | 1.5% |
Axonics Modulation Technologies Inc | Health Care | 1.4% |
Cardlytics Inc | Information Technology | 1.4% |
Stitch Fix Inc | Consumer Discretionary | 1.4% |
SunPower Corp | Information Technology | 1.4% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Holding | Sector | Assets |
---|
Inspire Medical Systems Inc | Health Care | 2.0% |
Axon Enterprise, Inc. | Industrials | 1.8% |
Natera Inc | Health Care | 1.7% |
RH | Consumer Discretionary | 1.5% |
TG Therapeutics Inc | Health Care | 1.5% |
MKS Instruments Inc | Information Technology | 1.5% |
Cardlytics Inc | Information Technology | 1.4% |
Axonics Modulation Technologies Inc | Health Care | 1.4% |
SunPower Corp | Information Technology | 1.4% |
Stitch Fix Inc | Consumer Discretionary | 1.4% |
Silvergate Capital Corp | Financials | 1.4% |
Crocs Inc | Consumer Discretionary | 1.3% |
Sonos Inc | Consumer Discretionary | 1.3% |
Five9 Inc | Information Technology | 1.3% |
Helen of Troy Ltd | Consumer Discretionary | 1.3% |
Digital Turbine Inc | Information Technology | 1.3% |
Western Alliance Bancorp | Financials | 1.3% |
Chart Industries Inc | Industrials | 1.3% |
Shift4 Payments Inc | Information Technology | 1.2% |
Deckers Outdoor Corp | Consumer Discretionary | 1.2% |
Twist Bioscience Corp | Health Care | 1.2% |
National Vision Holdings Inc | Consumer Discretionary | 1.2% |
Endava PLC | Information Technology | 1.2% |
Insmed Inc | Health Care | 1.2% |
Evoqua Water Technologies Corp | Industrials | 1.2% |
Malibu Boats Inc | Consumer Discretionary | 1.2% |
Semtech Corp | Information Technology | 1.2% |
TPI Composites Inc | Industrials | 1.2% |
LGI Homes Inc | Consumer Discretionary | 1.2% |
Goosehead Insurance Inc | Financials | 1.1% |
Inari Medical Inc | Health Care | 1.1% |
Turning Point Therapeutics Inc | Health Care | 1.1% |
Q2 Holdings Inc | Information Technology | 1.1% |
Bridgebio Pharma Inc | Health Care | 1.1% |
Wingstop Inc | Consumer Discretionary | 1.1% |
CareDx Inc | Health Care | 1.1% |
CEVA Inc | Information Technology | 1.1% |
Sprout Social Inc | Information Technology | 1.1% |
Appian Corp | Information Technology | 1.1% |
YETI Holdings Inc | Consumer Discretionary | 1.1% |
Rocket Pharmaceuticals Inc | Health Care | 1.0% |
Ultragenyx Pharmaceutical Inc | Health Care | 1.0% |
SVMK Inc | Information Technology | 1.0% |
Generac Holdings Inc | Industrials | 1.0% |
Nevro Corp | Health Care | 1.0% |
Sunrun Inc | Industrials | 1.0% |
Blueprint Medicines Corp | Health Care | 1.0% |
Globant SA | Information Technology | 1.0% |
Blackline Inc | Information Technology | 0.9% |
Calix Inc | Information Technology | 0.9% |
Redfin Corp | Real Estate | 0.9% |
Fiverr International Ltd | Consumer Discretionary | 0.9% |
Pacific Biosciences of California Inc | Health Care | 0.9% |
Diodes Inc | Information Technology | 0.9% |
Skillz Inc | Communication Services | 0.9% |
Acceleron Pharma Inc | Health Care | 0.9% |
Novavax Inc | Health Care | 0.8% |
AZEK Co Inc/The | Industrials | 0.8% |
Constellation Pharmaceuticals Inc | Health Care | 0.8% |
Freshpet Inc | Consumer Staples | 0.8% |
Altra Industrial Motion Corp | Industrials | 0.8% |
Lumentum Holdings Inc | Information Technology | 0.8% |
Shockwave Medical Inc | Health Care | 0.8% |
Rapid7 Inc | Information Technology | 0.8% |
Arena Pharmaceuticals Inc | Health Care | 0.8% |
Iovance Biotherapeutics Inc | Health Care | 0.8% |
Repligen Corp | Health Care | 0.8% |
Hydrofarm Holdings Group Inc | Industrials | 0.8% |
Paylocity Holding Corp | Information Technology | 0.8% |
LiveRamp Holdings Inc | Information Technology | 0.7% |
Brooks Automation Inc | Information Technology | 0.7% |
Stamps.com Inc | Consumer Discretionary | 0.7% |
Trex Co Inc | Industrials | 0.7% |
Everbridge Inc | Information Technology | 0.7% |
Trupanion Inc | Financials | 0.7% |
Planet Fitness Inc | Consumer Discretionary | 0.7% |
RealReal Inc/The | Consumer Discretionary | 0.7% |
Adaptive Biotechnologies Corp | Health Care | 0.7% |
Quanterix Corp | Health Care | 0.7% |
CRISPR Therapeutics AG | Health Care | 0.7% |
Balchem Corp | Materials | 0.7% |
Littelfuse Inc | Information Technology | 0.6% |
Cerence Inc | Information Technology | 0.6% |
Jamf Holding Corp | Information Technology | 0.6% |
Array Technologies Inc | Industrials | 0.6% |
Schrodinger Inc/United States | Health Care | 0.6% |
Myovant Sciences Ltd | Health Care | 0.6% |
Penn National Gaming Inc | Consumer Discretionary | 0.6% |
Mirati Therapeutics Inc | Health Care | 0.5% |
NanoString Technologies Inc | Health Care | 0.5% |
ChemoCentryx Inc | Health Care | 0.5% |
Berkeley Lights Inc | Health Care | 0.5% |
Bloom Energy Corp | Industrials | 0.5% |
Upwork Inc | Industrials | 0.5% |
Rush Enterprises Inc | Industrials | 0.5% |
Lightspeed POS Inc | Information Technology | 0.5% |
Seres Therapeutics Inc | Health Care | 0.4% |
Magnite Inc | Consumer Discretionary | 0.4% |
SI-BONE Inc | Health Care | 0.4% |
Intra-Cellular Therapies Inc | Health Care | 0.4% |
Karuna Therapeutics Inc | Health Care | 0.4% |
Scholar Rock Holding Corp | Health Care | 0.3% |
Datto Holding Corp | Information Technology | 0.2% |
Danimer Scientific Inc | Materials | 0.2% |
Certara Inc | Health Care | 0.1% |
Shoals Technologies Group Inc | Industrials | 0.0% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 01/29/2021
Sector | Weighting | Fund Change from Previous Quarter |
---|
Sector | Weighting | Fund Change from Previous Quarter |
---|---|---|
Communication Services |
![]() |
|
Real Estate |
![]() |
|
Utilities | 0.0% | |
Consumer Discretionary |
![]() |
|
Consumer Staples |
![]() |
|
Energy | 0.0% | |
Financials |
![]() |
|
Health Care |
![]() |
|
Industrials |
![]() |
|
Information Technology |
![]() |
|
Materials |
![]() |
Portfolio Details as of 01/29/2021
- Total Net Assets
- $4.97 B
- Number of Holdings
- 106
- Weighted Average Market Cap.
- 5.9 B
- P/B Ratio
- 8.5x
- P/E Ratio
- 42.5x
To view definitions for the above Portfolio Details, Click here.
Market Capitalization Breakdown - Morningstar separates stock portfolio holdings into five market-capitalization groups: Giant, Large, Mid, Small, and Micro. Of the 5000 largest domestic stocks in their equities database, the top 1% are categorized as Giant, the next 4% are Large, the next 15% are Mid, the next 30% are Small, and the remaining 50% are Micro. Stocks outside of the largest 5000 are also classified as Micro.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Contributors & Detractors as of 12/31/2020
Contributors
Holding | Contribution |
---|---|
Appian Corp | 1.6% |
Cardlytics Inc | 1.0% |
Enphase Energy, Inc. | 1.0% |
TG Therapeutics Inc | 0.9% |
Bridgebio Pharma Inc | 0.8% |
Detractors
Holding | Contribution |
---|---|
Overstock.com Inc | -0.3% |
Stamps.com Inc | -0.3% |
Seres Therapeutics Inc | -0.2% |
Tandem Diabetes Care Inc | -0.2% |
Limelight Networks, Inc. | -0.2% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
Developing Growth Fund | Benchmark | Variance | |||||
---|---|---|---|---|---|---|---|
Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to the Fund's performance results for longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
Record Date | Ex-Dividend Date | Reinvest & Payable Date |
---|---|---|
11/22/2021 | 11/23/2021 | 11/23/2021 |
Capital Gains Distributions
Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
---|---|---|---|---|---|
11/23/2020 | 11/24/2020 | $2.1959 | $0.7588 | $2.9547 | $34.71 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Upcoming Capital Gain Distribution
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
Record Date | Ex-Dividend Date |
---|---|
11/22/2021 | 11/23/2021 |
Fees & Expenses
Fees & Expenses
Expense Ratioas of 02/28/2021
0.68% |
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
0Documents selected
|
Order | ||||
---|---|---|---|---|---|
n/a |
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
n/a |
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
Summary Prospectus
Publish Date:11/03/2015
|
|||||
n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
n/a |
Prospectus (XBRL)
Publish Date:11/03/2015
|
||||
SAI
Publish Date:11/03/2015
|
|||||
Annual Report
Publish Date:11/03/2015
|
|||||
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
Fact Sheet
Publish Date:11/03/2015
|
|||||
Commentary
Publish Date:11/03/2015
|
|||||
Fund Story
Publish Date:11/03/2015
|